Decision Diagnostics Announces Engagement of Mark Krakauer to Head Up Genstrip Private Label Sales Efforts

Industry Legend and Founder of Private Label Manufacturers Association to Spearhead Sales for DECN's Core Genstrip Business

LOS ANGELES, CA--(Marketwired - Mar 11, 2014) - Decision Diagnostics Corp. (OTCQB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip™, the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's LifeScan Ultra family of glucose testing meters, today announced that that the Company has engaged Mark Krakauer to lead the company's private label marketing strategy. Mr. Krakauer is President of MWK Marketing, Inc. and a founder of the Private Label Manufacturers Association.

"I am delighted to be a part of Pharma Tech Solutions. I believe strongly in the Genstrip, and have presented the product to my customer business base, which includes chain pharmacies, group buying organizations, major supermarket chains, mass merchants, and the large distributors in the medical product space. Not coincidently we have received verbal offers from three of my larger customers. We are currently working on enterprise marketing plans for these groups which the company has informed me that they will announce shortly."

The company reminds shareholders and all interested parties that it is currently airing its GenStrip commercial video titled, "A Winter Patchwork" in every region of the country, and is completing its new series of commercials titled Monolith. The company's upcoming media schedule calls for almost 20,000 total 30 second buys with the commercial playing all hours of the day except for late morning and dinner hours. The current video is available for viewing at: http://shastagenstrip.com/winter_ad.html or http://youtu.be/j0njOGSSKtQ.

Keith Berman, Principal Executive Officer of DECN concluded, "There are times when the right product in the right space allows for things to just fall into place. The engagement of Mark Krakauer will boost Genstrip in a market channel where we are relative newcomers, but where Mark has spent the last 36 years becoming the authority in an industry channel he founded. This engagement could not have happened at a better time for DECN."

Forward Looking Statements:

This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions.

For further information about Shasta GenStrip, please visit the company's Web Sites: http://www.decisiondiagnostics.com/ or http://www.shastagenstrip.com/.

GenStrip™ test strips are a product of Shasta Technologies, LLC and are not manufactured, distributed, endorsed, or approved by nor associated with LifeScan®, Inc. a Johnson & Johnson® Company, manufacturers and distributors of the OneTouch® Ultra® Family of Meters and OneTouch® Ultra® test strips.

Contact: Decision Diagnostics Corp. Keith Berman (805) 446-2973 info@decisiondiagnostics.com

Decision Diagnostics (CE) (USOTC:DECN)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Decision Diagnostics (CE) Charts.
Decision Diagnostics (CE) (USOTC:DECN)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Decision Diagnostics (CE) Charts.